DEF 14AThe Ballot
Spyre Therapeutics, Inc. files DEF 14A
Filed Apr 23, 2020 · 6y ago · Accession 0001564590-20-018057
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- DEF 14A
- Filing date
- Apr 23, 2020
- Report date
- Jun 8, 2020
- Document
- agle-def14a_20200608.htm
- Size
- 860 KB